-
A Career I Never Planned, a Mission I Never Expected
Invisible Disability
-
Beacon Stories
-
“Asking for Help Is Not a Weakness”
Beacon Stories
Our Impact
The Foundation is committed to driving research advancing treatments and cures for people with blinding diseases.
-
1st gene therapy
for any inherited disease to be approved by the FDA
learn more -
$996M dollars raised
since 1971
learn more -
255,000+ walkers, donors, and corporate sponsors
have raised more than $78 million through VisionWalk since Spring 2006.
learn more -
104 grants awarded
in 2026 – over 126 investigators, 96 institutions
Learn more
Latest Research News
Emerging gene therapy for RDH12-associated Leber congenital amaurosis cleared for clinical trials
-
Oct 2, 2026
Early clinical trial results show vision gains in patients with BEST1-related disease
Research News -
Sep 22, 2026
Beacon's emerging XLRP gene therapy improves low-light vision in phase 3 trial
Research News -
Sep 18, 2026
Nanoscope’s investigational RP treatment MOGENRY advances toward FDA approval
Research News
Living with vision loss can be difficult, but you don’t have to do it alone.
Get Involved
-
Take important steps toward treatments and cures by participating in a 5k VisionWalk
Join a Walk -
Join others in your community committed to advancing treatments and cures
Search Our Events -
Make a difference today and support promising research by donating a one-time gift
Donate Now